Archive

Lenacapavir HIV prevention offers twice-yearly PrEP, but trust, access, stigma and continued engagement will determine its impact.

Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.

AI alternatives to animal testing can predict toxicity and organ damage while offering more ethical and human-relevant research methods.

US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.

iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.

SA’s PEPFAR funding could end as the FW de Klerk Foundation urges Donald Trump to protect vital HIV services and infrastructure.

Contraceptive shortages hit South Africa following Aspen’s manufacturing issues, prompting alternatives for the public health sector.

Medical scheme clawbacks remain lawful after the High Court rejected a challenge to Section 59(3) of the Medical Schemes Act.

The GEMS 2026 contribution increase has repercussions for the public servants’ medical schemes amidst rising healthcare costs.

AI Healthcare Tools are helping South African doctors reduce admin, improve clinical notes and free up more time for patient care.

Explore European drug-pricing policies and how they impact healthcare spending and patient access to life-saving medicines.